DOCSLIB.ORG

Gats India Report.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Gats India Report.Pdf GATS India Report 2009-2010 Ministry of Health and Family Welfare Government of India GLOBAL ADULT TOBACCO SURVEY GATS INDIA 2009-2010 GATS India Report 2009-2010 © Ministry of Health and Family Welfare, Government of India, New Delhi. All rights reserved. The contents in this publication may be reproduced or translated free of charge after taking prior permission of the National Tobacco Control Programme, Ministry of Health & Family Welfare, Government of India, New Delhi – 110 011. However, short excerpts may be reproduced without authorization, on condition that the source is indicated and duly acknowledged. The material has to be reproduced accurately and not to be used in a derogatory manner or in a misleading context. The permission to reproduce this material shall not extend to any material which is identified as being copyright of a third party. The authorization to reproduce such material must be obtained from the departments/copyright holders concerned. This publication is also available on the website www.iipsindia.org, www.mohfw.nic.in. The Global Adult Tobacco Survey (GATS) India, 2009-2010 has been conducted by the International Institute for Population Sciences, Mumbai as per the standard protocol under Global Tobacco Surveillance System (GTSS). All reasonable precautions have been taken by the Ministry of Health & Family Welfare to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. Inquiries if any may be addressed to International Institute for Population Sciences, Govandi Station Road, Deonar, Mumbai-400 088 or email [email protected], [email protected]. The copy of this report may be obtained from International Institute for Population Sciences, Deonar, Mumbai – 400 088, as per the existing policy. Printed in India, 2010 GATS India Report 2009-2010 iiiii GATS India Report 2009-2010 v GATS India Report 2009-2010 viivii GATS India Report 2009-2010 ixix GATS India Report 2009-2010 xi GATS India Report 2009-2010 ACKNOWLEDGEMENT The 2009-2010 Global Adult Tobacco Survey (GATS) in India was successfully completed with the committed efforts and support of different organizations and individuals at various stages of the survey. At the outset we acknowledge our sincere gratitude to the Ministry of Health and Family Welfare (MoHFW), Government of India, for granting responsibility of conducting the Global Adult Tobacco Survey (GATS) in India to IIPS, Mumbai, and funding this project. We express our thanks to Miss. K. Sujatha Rao, Secretary to the Government of India, MoHFW; Dr. R. K. Srivastava, Director General of Health Services (DGHS); Shri Keshav Desiraju, Additional Secretary (H); Dr. Dinesh Bhatnagar, Additional Director General, Ms. Madhubala, ADG (Stats); Shri. S.K. Das, Former Additional Director General (Stats); Sh. B.K. Prasad, Joint Secretary, and Dr. D.C. Jain, DDG (NCD); for providing overall guidance and support during the tenure of the project. We wish to put on record the contributions of Late Prof. P. N. Mari Bhat, the former Director & Sr. Professor (2005 -2007) of the IIPS, Mumbai, who was instrumental in undertaking the GATS-India project at the initial stage. We gratefully acknowledge valuable suggestions and contributions by Ms. Anuradha Vemuri, Director, MoHFW; Dr. Rattan Chand, Chief Director (Stats); Dr. Jagdish Kaur, Chief Medical Officer and Dr. Vinayak Prasad, former Director (PH) at various stages of the survey. We extend our appreciation to all collaborative partner organizations viz., World Health Organization (WHO) Country office for India, WHO SEARO; Centers for Disease Control and Prevention (CDC); CDC Foundation, Atlanta; Research Triangle Institute (RTI) International and Johns Hopkins Bloomberg School of Public Health (JHSPH) for providing technical support in successfully conducting the GATS in India. We gratefully acknowledge the immense help and guidance received time to time from Dr. Samira Asma, Associate Director, CDC-Atlanta and Dr. Krishna Mohan Palipudi, Senior Survey Statistician, CDC- Atlanta for their constant involvement and support at various stages of the project. We sincerely acknowledge the WHO’s contribution to the project with special thanks to Dr. D. N. Sinha, Regional Surveillance Officer, WHO-SEARO and Ms. Vineet Gill Munish, National Professional Officer (TFI), WHO, India. Our special thanks to all the members of Technical Advisory Committee and Technical Review Committee in particular Dr. K. Srinath Reddy, President, Public Health Foundation of India (PHFI), New Delhi and Dr. P. C. Gupta, Director, Healis-Sekhsaria Institute for Public Health, Mumbai. This acknowledgement cannot be concluded without expressing appreciation for the efforts and hard work put in by the field investigators and supervisors in collecting data and all data managers for timely transferring data to IIPS. Last but not the least, credit goes to all respondents who participated in GATS-India project. L. Ladu Singh F. Ram B. Paswan S. Lahiri S. K. Singh Sulabha Parasuraman K. C. Das xiii GATS India Report 2009-2010 CONTRIBUTORS Prof. F. Ram Prof. S. Lahiri Prof. Sulabha Parasuraman Prof. L. Ladu Singh Prof. B. Paswan Dr. S. K. Singh Dr. K. C. Das xv GATS India Report 2009-2010 TECHNICAL ADVISORY COMMITTEE Chairman: Additional Secretary/ Joint Secretary in-charge of Tobacco Control Programme, MoHFW, GOI Co-Chairman: Additional DG (Stats.), Dte.GHS, MoHFW Members: Shri Keshav Desiraju, Additional Secretary (H), MoHFW Shri V. Venkatachalam, Additional Secretary, MoHFW Shri Prabir Krishan, Joint Secretary, MoHFW Shri B.K. Prasad, Joint Secretary MoHFW Dr. Amarjit Singh, Former Joint Secretary, MoHFW Dr. Dinesh Bhatnagar, Addl DG (DB), Dte.GHS, MoHFW Shri. S. K. Das, Former ADG (Stats.), MoHFW Dr. Rattan Chand, Chief Director (Stats.), MoHFW Ms. Anuradha Vemuri, Director, MoHFW Dr. Jagdish Kaur, Chief Medical Officer, Dte.GHS, MoHFW Dr. Vinayak M. Prasad, Former Director (PH), MoHFW Prof. F. Ram, Director, IIPS Prof. S. Lahiri, IIPS Prof. Sulabha Parasuraman, IIPS Prof. L. Ladu Singh, IIPS Prof. B. Paswan, IIPS Dr. S. K. Singh,Associate Professor, IIPS Dr. K. C. Das, Associate Professor, IIPS Dr. K. Srinath Reddy, President, Public Health Foundation of India, Delhi Dr. P. C. Gupta, Director, Healis-Sekhsaria Institute of Public Health, Mumbai Dr. D. N. Sinha, Technical Officer- TFI, WHO-SEARO Ms. Vineet Gill Munish, NPO-Tobacco Free Initiative, WHO India Dr. Samira Asma,Associate Director, CDC, Atlanta Dr. Krishna Mohan Palipudi, Senior Survey Statistician,CDC, Atlanta xvi GATS India Report 2009-2010 TECHNICAL REVIEWERS Dr. P. C. Gupta, Director, Healis-Sekhsaria Institute of Public Health, Mumbai Dr. K. Srinath Reddy, President, Public Health Foundation of India, Delhi Ms. Monika Arora, PHFI Ms. Anuradha Vemuri, Director, MoHFW Dr. Jagdish Kaur, Chief Medical Officer, Dte.GHS, MoHFW Dr. D. N. Sinha, Technical Officer- TFI, WHO-SEARO Dr. Samira Asma, Associate Director, CDC, Atlanta Dr. Krishna Mohan Palipudi, Senior Survey Statistician,CDC, Atlanta Ms. Vineet Gill Munish, NPO-Tobacco Free Initiative, WHO India Dr. Vinayak Prasad, Former Director (PH), MoHFW Edited by: Smt. Rita Vohra Editorial Assistant: Ms. Pooja Gupta Mr.Anand Kumar Panjiyar xvii GATS India Report 2009-2010 CONTENTS Page No. TABLES……………………………………….………………………………..…...........xv FIGURES………………………………….………………………….………............. xxiv MAPS……………………………………………………….………...………………. xxvii EXECUTIVE SUMMARY………………………..……………………………........xxviii CHAPTER 1 INTRODUCTION.………………………………………………………………………1 1.1 Tobacco Control Policies in India…………………………………….................................2 1.2 Tobacco Use in India……………………………………………………….………...…….3 1.3 Survey Objectives…………………………………………………………………….........7 CHAPTER 2 METHODOLOGY…………………………………………………………….................9 2.1 Study Population………………………………………………………………..…….....…9 2.2 Sampling Design…………………………………………………………………….…..…9 2.3 Questionnaire……………………………………………………………………..............11 2.4 Questionnaire Programming and Preparation of Handheld Computers……….………....12 2.5 Recruitment, Training and Fieldwork……………………………………………….........13 2.6 Data Processing and Aggregation………………………..……………………...………..16 2.7 Statistical Analysis…………………………………………………………………......…17 CHAPTER 3 SAMPLE AND POPULATION CHARACTERISTICS…………..……….…………19 3.1 Sample Coverage, Household and Person-Level Response Rates………..………...….…19 3.2 Characteristics of Sampled Respondents……………………………………………..…...23 3.3 States and Regional Population Distribution………………………………………..….....24 CHAPTER 4 TOBACCO USE………………………………………………………….………..........25 4.1 Tobacco Use…………………………………………………………………..………..…25 4.2 Tobacco Smoking…………………………………………………………………...….....43 4.3 Use of Smokeless Tobacco …..…………………………………………………….….….72 CHAPTER 5 TOBACCO CESSATION…………………………………………………....…...….…97 5.1 Cessation Attempts, Health Care Seeking Behaviour of Tobacco Users and Advice by Health Care Providers……………………………………..……………...…..97 5.2 Cessation Method.………………………………………………………………......…...105 5.3 Interest in Quitting Tobacco………………………………………………………..........110 5.4 Duration of Stopping Tobacco Use………………………………………………...……116 xix GATS India Report 2009-2010 CHAPTER 6 SECOND-HAND SMOKE…………………………………………...…………….….123 6.1 Exposure to Second-Hand Smoke (SHS) in Indoor Workplaces…………...………...…123 6.2 Exposure to Second-Hand Smoke at Home……………………………….………….…127 6.3 Exposure to Second-Hand Smoke at Various Public Places……………………….…....131 6.4 Designated Non-Smoking Area and Smoking in Designated
Load more

Recommended publications
  • Global Tobacco Control: What the U.S. Can Learn from Other Countries (2013)
    A Law Synopsis by the Tobacco Control Legal Consortium September 2013 Global Tobacco Control: Tobacco Control What the U.S. Can Learn from Other Countries Legal Consortium Leslie Zellers Law. Health. Justice. This synopsis is provided for educational purposes only and is not to be construed as a legal opinion or as a substitute for obtaining legal advice from an attorney. Laws cited are current as of June 30, 2013. The Tobacco Control Legal Consortium provides legal information and education about tobacco and health, but does not provide legal representation. Readers with questions about the application of the law to specific facts are encouraged to consult legal counsel familiar with the laws of their jurisdictions. Suggested citation: Leslie Zellers, Tobacco Control Legal Consortium, Global Tobacco Control: What the U.S. Can Learn from Other Countries (2013) Tobacco Control Legal Consortium 875 Summit Avenue Saint Paul, Minnesota 55105 USA www.publichealthlawcenter.org 651.290.7506 Copyright © 2013 Tobacco Control Legal Consortium Global Tobacco Control: Global Tobacco Control: What the U.S. Can Learn from Other Countries What the U.S. Can Learn from Other Countries Leslie Zellers I. Introduction implementing the strategy, discusses opposition to the particular strategy (usually from the tobacco Although tobacco use is decreasing in the Unit- industry), reviews any unintended consequences ed States, globally the tobacco epidemic kills or challenges in implementing the policy, and nearly six million people each year, with 80% finally, provides information on the strategy’s of the deaths occurring in low- and middle- effectiveness as a public health measure. In a few income countries.
    [Show full text]
  • Rationale for Increasing the Age for Sale for Tobacco in England from 18 to 21
    Rationale for Increasing the Age for sale for tobacco in England from 18 to 21 Deborah Arnott, honorary associate professor, University of Nottingham and chief executive, Action on Smoking and Health Professor Richard Ashcroft, Deputy Dean of the Law School at City, University of London Kate Pike, Regional Co-ordinator, Trading Standards North West Professor Robert West, Emeritus Professor, Behavioural Science and Health, University College London Citation for this document: Arnott D, Ashcroft R, Pike K, West R. Rationale for Increasing the Age for sale for tobacco in England from 18 to 21. London: ASH, 2021. Introduction 1. The uniquely harmful impact of tobacco and smoking, and a global recognition of the need for strict regulation, is enshrined in the WHO Framework Convention on Tobacco Control (FCTC). The treaty, which over 180 countries including the UK have committed to uphold, includes an obligation to restrict the supply of, and demand for, tobacco. 2. The UK is a world leader in implementation of the FCTC, having banned advertising, put tobacco out of sight in shops and required packaging to be standardised with large graphic health warnings, as well as providing help for smokers to quit and having high rates of taxation to reduce affordability. However, policy measures already in place have not been sufficient to end smoking, and youth uptake remains a significant problem.1 3. As Parties to the FCTC we are encouraged to implement measures beyond those required by the FCTC and its protocols.2 Increasing the age of sale, as part of a comprehensive tobacco control strategy, is an important policy measure which can help deliver a smokefree generation and a Smokefree society by 2030 in line with the ambition of our government, supported by the public, and civil society.
    [Show full text]
  • Emerging Issues in Tobacco Control
    Emerging Issues in Tobacco Control S p e a k e r s : Molly Cotant, MPH Elaine Lyon, MA Laura de la R ambelje, MA Susan Pulaski, MA, CPC - M October 8, 2015 What is Tobacco 21? Raising the minimum age of legal access to tobacco products to 21 years of age “Raising the legal minimum age for cigarette purchaser to 21 could gut our key young adult market (17-20) where we sell about 25 billion cigarettes and enjoy a 70% market share.” Philip Morris report, January 21, 1986 Tobacco Use – A Critical Public Health Issue Cigarette smoking is the leading cause of preventable disease and death in the U.S. Each year, more than 16,200 Michiganders die from tobacco use 10,300 Michigan children become new regular, daily smokers annually, 1/3 of whom will die prematurely due to this addiction. E-cigarette use is rising rapidly among youth. The young adult brain and addiction Parts of the brain most responsible for decision making, impulse control, sensation seeking and susceptibility to peer pressure continue to develop and change through young adulthood More susceptible to addiction since the brain is not fully mature: adolescent brains are uniquely vulnerable to the effects of nicotine Source: Institute of Medicine The young adult brain and addiction Because of nicotine addiction, approximately 3 out of 4 teen smokers continue smoking into adulthood, even if they intended to quit after a few years. 95% of adults began smoking before age 21 4 out of 5 become regular, daily smokers before age 21 Studies show earlier onset of tobacco use make it harder to quit later should a person choose to do so.
    [Show full text]
  • Tobacco Control
    TOBACCO CONTROL Playbook World Health Organization ABSTRACT Tobacco control is difficult and complex and obstructed by the tactics of the tobacco industry and its allies to oppose effective tobacco control measures. This document was developed by the WHO Regional Office for Europe by collecting numerous evidence-based arguments from different thematic areas, reflecting the challenges that tobacco control leaders have faced while implementing various articles of the WHO FCTC and highlighting arguments they have developed in order to counter and succeed against the tobacco industry. KEY WORDS TOBACCO CONTROL WHO FCTC HEALTH EFFECTS TOBACCO INDUSTRY ARGUMENTS © World Health Organization 2019 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication.
    [Show full text]
  • 313.Full.Pdf
    Research paper Tob Control: first published as 10.1136/tc.2011.043000 on 20 July 2011. Downloaded from Gainfully employed? An inquiry into bidi-dependent livelihoods in Bangladesh Anupom Roy,1 Debra Efroymson,2 Lori Jones,3 Saifuddin Ahmed,4 Islam Arafat,4 Rashmi Sarker,4 Sian FitzGerald3 1Department of Anthropology, ABSTRACT losses in the tobacco sector.9 10 Studies assessing Macquarie University, New Objectives This study sought to increase government, the impact of price and income on consumption South Wales, Australia 2 civil society and media attention to the tobaccoepoverty behaviour demonstrate that price responsiveness is HealthBridge Foundation of Canada, Dhaka, Bangladesh connection in Bangladesh, particularly as it relates to greatest among the socioeconomically disadvan- 3HealthBridge Foundation of bidi-dependent livelihoods. taged and that the poor gain the greatest economic e Canada, Ottawa, Canada Data sources This study consisted of a literature review benefit from reduced tobacco consumption.11 20 4 WBB Trust, Dhaka, Bangladesh that examined the socioeconomic impacts of tobacco Such studies support the use of tax increases as part farming, the working conditions of tobacco workers and of a cost-effective strategy to reduce tobacco use. Correspondence to d Anupom Roy, Department of the impact of tobacco on consumers, and a primary Some governments particularly in lower Anthropology, Macquarie research study among bidi workers and users. The income countriesduse employment and tax University, North Ryde, New research included in-depth and semistructured interviews revenue arguments to justify their unwillingness to South Wales, 2109, Australia; and focus group discussions among bidi workers and take stronger steps against tobacco,21 22 even while [email protected] a closed-ended quantitative survey among bidi users.
    [Show full text]
  • Tobacco 21: Raising the Legal Sales Age
    Tobacco 21: Raising the Legal Sales Age David M. Horn Senior Counsel Washington Attorney General’s Office Tobacco 21 INTRODUCTION & Disclaimer A. Why Raise the Age? Tobacco Have we won the war? Youth tobacco use Youth tobacco use BUT In 2015 25.3% of high school students had used a tobacco product in the last 30 days In 2015 Youth 30-day use of any tobacco products: -stopped declining in 2013 -has been increasing since Tobacco What to do? What Is the Science Base On Tobacco 21? • 2009 - Family Smoking Prevention and Tobacco Control Act directs the Food and Drug Administration to study the public health implications of raising the tobacco sale age. • 2013 - FDA contracts with the Institute of Medicine to: • Examine the existing academic literature on tobacco use initiation • Predict the likely public health outcomes of raising the tobacco sale age • 2015 – The report, The Public Health Implications of Raising the Minimum Age of Legal Access to Tobacco Products predicts substantial improvements in public health. Campaign for Tobacco-Free Kids www.tobaccofreekids.org IOM Study – Age to 21 Reduces smoking initiation: *25% @ 15-17 *15% @ under 15 *15% @ 18-20 Tobacco 21 Smoking Delayed = Smoking Prevented Why Raise the Age? Tobacco companies know that if they don’t capture new users by their early 20’s, it’s unlikely that they ever will. “If a man has never smoked by age 18, the odds are three-to-one that he never will. By age 24, the odds are twenty-to-one.” —RJ Reynolds, September 10, 1982 14 Campaign for Tobacco-Free Kids www.tobaccofreekids.org IOM Study – Age to 21 Reduces smoking prevalence by 12% IOM Study – Age to 21 • over the long term, there will be: • 223,000 fewer premature deaths • 50,000 fewer deaths from lung cancer • 4.2 million fewer years of life lost.
    [Show full text]
  • Federal Tobacco 21: the Law of Land
    FEDERAL TOBACCO 21: THE LAW OF LAND In December 2019, Congress passed a $1.37 trillion spending bill that included a provision to raise the minimum legal sales age for all tobacco products from 18 to 21 nationwide. Upon the President’s signature on December 20, 2019, the age change became effective immediately. • It is now a violation of federal law for any retailer to sell any nicotine or tobacco products to anyone under the age of 21. • FDA will oversee enforcement of the minimum legal sales age at 21. • There are no exemptions for sales to members of the military who are under 21. • The law does not phase-in age restrictions (i.e., there is no “grandfathering”) of those who are currently 18, 19 or 20. • The law does not preempt cities, counties or states from passing and enforcing their own age restriction laws and does not preempt Tobacco 21 laws already in place in cities, counties and states, except that no military or grandfathering exemptions are granted. • The law penalizes retailers for selling tobacco products to youth, not those attempting to purchase, although many states and cities retain purchase, use and possession (PUP) laws. • The law does not require that states pass laws to raise their sales age to 21, but it does require states to demonstrate that their retailers are complying with the law. If not, the state eventually risks losing some portion of their federal substance abuse grant funding. • This law does not address flavored tobacco or nicotine products in any way, although on January 2, 2020, the FDA issued an enforcement policy on unauthorized flavored cartridge based e-cigarettes: https://www.fda.gov/media/133880/download 1 Federal Tobacco 21 Law FAQ 1.
    [Show full text]
  • Page 1 of 15
    Updated September14, 2021– 9:00 p.m. Date of Next Known Updates/Changes: *Please print this page for your own records* If there are any questions regarding pricing of brands or brands not listed, contact Heather Lynch at (317) 691-4826 or [email protected]. EMAIL is preferred. For a list of licensed wholesalers to purchase cigarettes and other tobacco products from - click here. For information on which brands can be legally sold in Indiana and those that are, or are about to be delisted - click here. *** PLEASE sign up for GovDelivery with your EMAIL and subscribe to “Tobacco Industry” (as well as any other topic you are interested in) Future lists will be pushed to you every time it is updated. *** https://public.govdelivery.com/accounts/INATC/subscriber/new RECENTLY Changed / Updated: 09/14/2021- Changes to LD Club and Tobaccoville 09/07/2021- Update to some ITG list prices and buydowns; Correction to Pall Mall buydown 09/02/2021- Change to Nasco SF pricing 08/30/2021- Changes to all Marlboro and some RJ pricing 08/18/2021- Change to Marlboro Temp. Buydown pricing 08/17/2021- PM List Price Increase and Temp buydown on all Marlboro 01/26/2021- PLEASE SUBSCRIBE TO GOVDELIVERY EMAIL LIST TO RECEIVE UPDATED PRICING SHEET 6/26/2020- ***RETAILER UNDER 21 TOBACCO***(EFF. JULY 1) (on last page after delisting) Minimum Minimum Date of Wholesale Wholesale Cigarette Retail Retail Brand List Manufacturer Website Price NOT Price Brand Price Per Price Per Update Delivered Delivered Carton Pack Premier Mfg. / U.S. 1839 Flare-Cured Tobacco 7/15/2021 $42.76 $4.28 $44.00 $44.21 Growers Premier Mfg.
    [Show full text]
  • Toward a Comprehensive Long Term Nicotine Policy N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, P Boyle
    161 Tob Control: first published as 10.1136/tc.2004.010272 on 27 May 2005. Downloaded from SPECIAL COMMUNICATION Toward a comprehensive long term nicotine policy N Gray, J E Henningfield, N L Benowitz, G N Connolly, C Dresler, K Fagerstrom, M J Jarvis, P Boyle ............................................................................................................................... Tobacco Control 2005;14:161–165. doi: 10.1136/tc.2004.010272 abstinence from cigarette smoking by indefinite periods of Global tobacco deaths are high and rising. Tobacco use is use of other forms of nicotine such as nicotine gum and, in primarily driven by nicotine addiction. Overall tobacco Sweden, smokeless tobacco products. Such nicotine product control policy is relatively well agreed upon but a long term substitution appears to sustain the dependence on nicotine nicotine policy has been less well considered and requires while reducing the risk of smoking related diseases. A policy further debate. Reaching consensus is important because a that accepts only tobacco and nicotine abstinence as its goal nicotine policy is integral to the target of reducing tobacco flies in the face of the biology of tobacco addiction and would caused disease, and the contentious issues need to be seem to condemn many tobacco users to their course toward resolved before the necessary political changes can be premature death. Alternatively, a policy that too liberally sought. A long term and comprehensive nicotine policy is promotes any form of nicotine as an alternative to smoking proposed here. It envisages both reducing the attractiveness could increase overall nicotine addiction, a prospect worri- and addictiveness of existing tobacco based nicotine delivery some to many in public health.
    [Show full text]
  • TOBACCO 21: Policy Evaluation for Comprehensive Tobacco Control Programs
    TOBACCO 21: Policy Evaluation for Comprehensive Tobacco Control Programs i Acknowledgements This guidance was developed by the Centers for Disease Control and Prevention’s Office on Smoking and Health (OSH) and RTI International to serve as a technical resource to help inform effective policy evaluation and implementation by state tobacco prevention and control programs. The following individuals from the Centers for Disease Control and Prevention, Office on Smoking and Health (OSH) helped contribute to the preparation of this publication: Rene Lavinghouze, MA, Health Scientist Nicole Kuiper, MPH, Health Scientist Rebecca Fils-Aime, MPH, Evaluation Fellow Megan Cotter, MPH, Evaluation Fellow Tamara Crawford, DBH, MPH, ORISE Fellow Yessica Gomez, MPH, Health Scientist Nikki Hawkins, PhD, Lead Health Scientist Monica Cornelius, PhD, MPH, Associate Service Fellow Briana Oliver, MPH, ORISE Fellow Cross-division workgroup members: Pamela Lemos, Sarah R. Lewis, Michael Tynan, and MaryBeth Welton The following partners also contributed to the preparation of this publication: Missouri University and the Missouri Department of Health and Senior Resources California Department of Public Health Hawaii State Department of Health New York City Department of Health and Mental Hygiene Maine Department of Health and Human Services A special thanks to RTI International for their contribution to the publication. Purpose The Centers for Disease Control and Prevention’s Office on Smoking and Health developed this guide to help state, local, territorial, and tribal health departments plan and implement evaluation of the federal law to raise the minimum legal sales age (MLSA) for tobacco products to 21 years (herein referred to as the T21 law). Guidance in this document can also support evaluation of state, local, territorial, and tribal T21 laws that may mirror or are more stringent than the federal T21 law (broadly referred to as T21 policies in this document).
    [Show full text]
  • State of Tobacco Control 2021” Evaluating States on Whether They Have Prohibited the Sale of All Flavored Tobacco Products
    2 Lung.org American Lung Association “State of Tobacco Control” 2021 “State of Tobacco Control” 2021: Preventing and Reducing Tobacco Use During the Time of COVID-19 The 19th annual American Lung Association “State of Tobacco Control” report evaluates states and the federal government on actions taken to eliminate the nation’s leading cause of preventable death—tobacco use—and save lives with proven-effective and urgently needed tobacco control laws and policies. The COVID-19 pandemic was clearly the main story of 2020, causing hundreds of thousands of deaths and disrupting the lives of everyone in the country. The U.S. Surgeon General has conclusively linked smoking to suppression of the immune system, and smoking increases the risk for severe illness from COVID-19, according to the Centers for Disease Control and Prevention (CDC). With the threat of COVID-19 in addition to the numerous tobacco-caused diseases, it is imperative to prevent youth from starting to use tobacco and to help everyone quit. Much like how COVID-19 has a disproportionate impact on certain communities, especially communities of color, so does tobacco use and exposure to secondhand smoke. Menthol cigarettes remain a key vector for tobacco-related death and disease in Black communities, with over 80% of Black Americans who smoke using them. Menthol cigarette use is Menthol in cigarettes plays also elevated among LGBTQ+ Americans, pregnant women and persons a significant role in youth with lower incomes. A recent study showed that while overall cigarette use declined by 26% over the past decade, 91% of that decline was becoming addicted to due to non-menthol cigarettes.1 This underscores what an FDA scientific cigarettes, masking the harsh advisory committee already found:2 menthol cigarettes are hard to quit, and taste of tobacco smoke and disproportionately affects Black communities.3 In addition, secondhand making the smoke easier to smoke exposure also occurs most often in hospitality establishments such as bars and casinos where people from Black and Brown communities more inhale.
    [Show full text]
  • TOBACCO 21 Fact Sheet
    TOBACCO 21 Fact Sheet What is Tobacco 21? “Tobacco 21” refers to the growing trend in which local and state governments pass laws prohibiting the sale of tobacco products, including electronic smoking devices (ESDs), to those under age 21, increasing that from age 18. As of August 2019, 50% of the U.S. population is covered by a Tobacco 21 policy as the law has been passed in 18 states and D.C. Maryland joined this public health effort in 2019 when the General Assembly passed HB1169, prohibiting the sale of tobacco products to those under the age 21. The law becomes effective on October 1, 2019. Changes to Current Law • Maryland’s Tobacco 21 law increases the legal sales age of tobacco products to 21 years, but exempts active duty members of the military who are at least 18 years old and who provide valid military ID upon purchase. • For purposes of the Business Regulation, Criminal Law, and Health-General Articles, the new law alters the term “Electronic Nicotine Delivery Systems” to “Electronic Smoking Devices.” Although there is change in terminology and definition, there is no significant change. The new definition is: o “A device that can be used to deliver aerosolized or vaporized nicotine to an individual inhaling from the device. It includes an electronic cigarette, an electronic cigar, an electronic cigarillo, an electronic pipe, an electronic hookah, a vape pen, and vaping liquid AND any component, part, or accessory of such a device regardless of whether or not it is sold separately, including any substance intended to be aerosolized or vaporized during use of the device.” • For purposes of the Business Regulation, Criminal Law, and Health-General Articles, “Electronic Smoking Devices” are now encompassed in the term “tobacco product.” • Criminal Law, §10-108 was repealed; those under the legal age of sale can no longer be cited for their purchase, use, or possession of these products.
    [Show full text]